“A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies”, Headache Med, vol. 11, no. 3, pp. 72–76, Sep. 2020, doi: 10.48208/HeadacheMed.2020.20.